Perspectives and challenges to discovering hemoglobin-inducing agents in Sickle Cell Disease

Perspectives and challenges to discovering hemoglobin-inducing agents in Sickle Cell Disease

Bibliographic Details
Main Authors:	Aline Renata Pavan, Juliana Romano Lopes, Carlos Henrique Lima Imperador, Chung Man Chin, Jean Leandro dos Santos
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2022-09-01
Series:	Frontiers in Medicine
Subjects:	Sickle Cell Disease fetal hemoglobin fetal hemoglobin inducers epigenetic NO/sCG/cGMP pathway clinical trials
Online Access:	https://www.frontiersin.org/articles/10.3389/fmed.2022.1002063/full

Similar Items

Efficacy of ruxolitinib as inducer of fetal hemoglobin in primary erythroid cultures from sickle cell and beta-thalassemia patients
by: Alice Pecoraro, et al.
Published: (2019-04-01)

Prevalence of Splenomegaly and Splenic Complications in Adults with Sickle Cell Disease and Its Relation to Fetal Hemoglobin
by: Jitendra D Lakhani, et al.
Published: (2022-10-01)

Serum of sickle cell disease patients contains fetal hemoglobin silencing factors secreted from leukocytes
by: Ikuta T, et al.
Published: (2018-06-01)

Limitations of mouse models for sickle cell disease conferred by their human globin transgene configurations
by: Kaitly J. Woodard, et al.
Published: (2022-06-01)

Evaluation of Signaling Pathways Involved in γ-Globin Gene Induction Using Fetal Hemoglobin Inducer Drugs
by: Fakher Rahim, et al.
Published: (2013-07-01)

Evaluation of Signaling Pathways Involved in γ-Globin Gene Induction Using Fetal Hemoglobin Inducer Drugs
by: Fakher Rahim, et al.
Published: (2013-09-01)

Estudo da correlação entre os níveis de hemoglobina fetal e o prognóstico dos pacientes com anemia falciforme Study of the correlation between fetal hemoglobin levels and the prognosis of patients with sickle cell anemia
by: Lilianne B. Silva, et al.
Published: (2009-01-01)

SAR1a promoter polymorphisms are not associated with fetal hemoglobin in patients with sickle cell disease from Cameroon
by: Gift Dineo Pule, et al.
Published: (2017-05-01)

Hydroxyurea ameliorates mouse hypoxia through inducing embryonic hemoglobin
by: ZHOU Xiaoying, et al.
Published: (2023-01-01)

Hydroxyurea-Induced miRNA Expression in Sickle Cell Disease Patients in Africa
by: Khuthala Mnika, et al.
Published: (2019-05-01)

MicroRNA29B induces fetal hemoglobin via inhibition of the HBG repressor protein MYB in vitro and in humanized sickle cell mice
by: Qingqing Gu, et al.
Published: (2022-11-01)

The protective effect of the spleen in sickle cell patients. A comparative study between patients with asplenia/hyposplenism and hypersplenism
by: Sari Peretz, et al.
Published: (2022-08-01)

HbF Levels in Sickle Cell Disease Are Associated with Proportion of Circulating Hematopoietic Stem and Progenitor Cells and CC-Chemokines
by: Caterina P. Minniti, et al.
Published: (2020-09-01)

Pharmacological Induction of Fetal Hemoglobin in β-Thalassemia and Sickle Cell Disease: An Updated Perspective
by: Rayan Bou-Fakhredin, et al.
Published: (2022-06-01)

The curious case of hemoglobin DC disease masquerading as sickle cell anemia
by: Samina Hirani, et al.
Published: (2020-05-01)

Effect of Gestational Hypertension on Neonatal Hemoglobin Level
by: Parisa Khosravi, et al.
Published: (2024-07-01)

Identification of genetic variants associated with clinical features of sickle cell disease
by: Katharine Tsukahara, et al.
Published: (2024-08-01)

Transcriptional regulators of fetal hemoglobin
by: Gabriela Pereira dos Santos, et al.
Published: (2024-11-01)

Blessing in disguise; a case of Hereditary Persistence of Fetal Hemoglobin
by: Irfan Shaukat, et al.
Published: (2018-11-01)

Association of ZBTB38 gene polymorphism (rs724016) with height and fetal hemoglobin in individuals with sickle cell anemia
by: Domício Antônio Costa-Júnior, et al.
Published: (2024-06-01)

Genotyping the BCL11A Single Nucleotide Polymorphism and Associated Levels of Fetal Hemoglobin in Mauritanian Sickle Cell Patients
by: Aminetou Taleb Brahim, et al.
Published: (2024-06-01)

Mathematical Modeling of Hydroxyurea Therapy in Individuals with Sickle Cell Disease
by: Akancha Pandey, et al.
Published: (2022-05-01)

Contribuição para a estimativa da freqüência populacional da Persistência Hereditária da Hemoglobina Fetal no Brasil Estimation of the frequency of Hereditary Persistence of Fetal Hemoglobin in Brazil
by: Vânia Aparecida da Costa, et al.
Published: (2002-10-01)

Phenotypic expression of HbO Indonesia in two Indian families and its interaction with sickle hemoglobin
by: Amar Das Gupta, et al.
Published: (2017-01-01)

Prevalência de hemoglobinopatias na população adulta brasileira: Pesquisa Nacional de Saúde 2014-2015
by: Luiz Gastão Rosenfeld, et al.

Estimated level of plasma micro RNA-210 in beta thalassemia patients and its relation to hemoglobin F level and disease severity
by: Homam M Sharshera, et al.
Published: (2023-01-01)

Is Hydroxyurea Treatment Changing the Life of Children with Sickle Cell Disease?
by: Mohammed Ali Al Sabbah, et al.
Published: (2023-07-01)

Simvastatin-Mediated Nrf2 Activation Induces Fetal Hemoglobin and Antioxidant Enzyme Expression to Ameliorate the Phenotype of Sickle Cell Disease
by: Caixia Xi, et al.
Published: (2024-03-01)

Promoter region sequence differences in the A and G gamma globin genes of Brazilian sickle cell anemia patients
by: C.G. Barbosa, et al.
Published: (2010-08-01)

ASSOCIATION BETWEEN FETAL HEMOGLOBIN LEVEL IN BLOOD AND THE ONSET OF RETINOPATHY OF PREMATURITY
by: WEI Hongli, ZHANG Lulu, SUN Mengya, XU Tong, LAI Chunchi, JIANG Hong
Published: (2023-02-01)

Evaluation of Novel Fetal Hemoglobin Inducer Drugs in Treatment of β-Hemoglobinopathy Disorders
by: Fatemeh Salari, et al.
Published: (2013-07-01)

Evaluation of Novel Fetal Hemoglobin Inducer Drugs in Treatment of β-Hemoglobinopathy Disorders
by: Ali Dehghani Fard, et al.
Published: (2013-09-01)

The Clinical Approach toward Hereditary Persistence of Fetal Hemoglobin: A Case Report
by: Afshin Ghaderi, et al.
Published: (2022-06-01)

Coinheritance of non‐deletional hemoglobin H disease with sickle cell trait
by: Veroniki Komninaka, et al.
Published: (2024-06-01)

Reference intervals for acetylated fetal hemoglobin in healthy newborns
by: Renata Paleari, et al.
Published: (2014-09-01)

Fetal hemoglobin, blood transfusion, and retinopathy of prematurity in preterm infants: An observational, prospective study
by: Nishi Prasad, et al.
Published: (2023-01-01)

Utility of paper-based sickle cell test compared to sodium metabisulfite sickling test using hemoglobin electrophoresis as a gold standard at Bugando Medical Center, Mwanza
by: Neema N Mkocha, et al.
Published: (2018-01-01)

Induction of Fetal Hemoglobin by Introducing Natural Hereditary Persistence of Fetal Hemoglobin Mutations in the γ-Globin Gene Promoters for Genome Editing Therapies for β-Thalassemia
by: Dian Lu, et al.
Published: (2022-05-01)

Unbinding of alpha chain of hemoglobin in sickle and normal structures
by: Jhulan Powrel, et al.
Published: (2025-01-01)

Reactivation of fetal hemoglobin in thalassemia and sickle cell disease
by: Sandro Eridani, et al.
Published: (2014-09-01)